Ignite Creation Date:
2025-12-24 @ 11:08 PM
Ignite Modification Date:
2025-12-30 @ 3:11 PM
Study NCT ID:
NCT01387269
Status:
COMPLETED
Last Update Posted:
2017-10-27
First Post:
2011-06-30
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety and Efficacy of Anamorelin HCl in Patients With Non-Small Cell Lung Cancer-Cachexia (ROMANA 1)
Sponsor:
Helsinn Therapeutics (U.S.), Inc
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-07
Start Date Type:
None
Primary Completion Date:
2014-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-02
Completion Date Type:
ACTUAL
First Submit Date:
2011-06-30
First Submit QC Date:
None
Study First Post Date:
2011-07-04
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-03-15
Results First Submit QC Date:
None
Results First Post Date:
2017-07-11
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2014-03-03
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2017-09-26
Last Update Post Date:
2017-10-27
Last Update Post Date Type:
ACTUAL